Company / Profit Margin
Niagen Bioscience, Inc. Profit Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
13.4%
FY2025
5-year range
-40.2% / 13.4%
FY2021-FY2025
Trend
+327.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Profit Margin changed +327% YoY in FY2025, a notable deviation from the 9-year average annual change of +17%.
Based on SEC 10-K filings.
13.4% in FY2025 with a 5-year CAGR of +82.9%.
Improved from -23.0% to 13.4% over the past 2 years.
Profit Margin over time
Growth rates
- 3-Year Change
- +53.6pp
- 5-Year Change
- +82.9pp
- 10-Year Change
- -
Key checks
Key Insights
- Niagen Bioscience, Inc.'s profit margin has grown for 3 consecutive years.
- In FY2025, profit margin increased 327.2% year-over-year.
- Lowest profit margin in the period was in FY2020.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 13.4% | +327.2% |
| FY2024 | -5.9% | +74.3% |
| FY2023 | -23.0% | +42.9% |
| FY2022 | -40.2% | -19.6% |
| FY2021 | -33.6% | +51.6% |
| FY2020 | -69.5% | +0.0% |
| FY2019 | -69.5% | -29.4% |
| FY2018 | -53.7% | +0.0% |
| FY2017 | -53.7% | -297.0% |
| FY2016 | -13.5% | +12.7% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026